Anthony A. DiTonno
2018
In 2018, Anthony A. DiTonno earned a total compensation of $645.8K as Chief Executive Officer at Tenax Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $80,625 |
|---|---|
| Option Awards | $256,556 |
| Salary | $278,333 |
| Other | $30,252 |
| Total | $645,766 |
DiTonno received $278.3K in salary, accounting for 43% of the total pay in 2018.
DiTonno also received $80.6K in non-equity incentive plan, $256.6K in option awards and $30.3K in other compensation.
Rankings
In 2018, Anthony A. DiTonno's compensation ranked 11,015th out of 14,244 executives tracked by ExecPay. In other words, DiTonno earned more than 22.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,015 out of 14,244 | 23rd |
Division Manufacturing | 4,439 out of 5,765 | 23rd |
Major group Chemicals And Allied Products | 1,682 out of 2,128 | 21st |
Industry group Drugs | 1,428 out of 1,817 | 21st |
Industry Pharmaceutical Preparations | 1,097 out of 1,391 | 21st |
Source: SEC filing on April 19, 2019.
DiTonno's colleagues
We found one more compensation record of an executive who worked with Anthony A. DiTonno at Tenax Therapeutics in 2018.
2018
Michael Jebsen
Tenax Therapeutics